Diabetes is the leading cause of nontraumatic amputations. Although laboratory assessment may not alone determine the optimal level of amputation thorough assessment of a variety of laboratory values is critical to overall care of the patient and may place the patient into risk category. This systematic review analyzes publications related to diabetic lower extremity amputations and associated laboratory values, including lymphocyte count, albumin, hemoglobin, and glycemic control.
ArmstrongDGLaveryLA. Diabetic foot ulcers: prevention, diagnosis and classification. Am Fam Physician. 1998;57:1325-1333.
2.
FrykbergRG. Epidemilogy of the diabetic foot: ulcerations and amputations. Adv Wound Care. 1999;12:139-146.
3.
BoykoEJAhroniJHStenselVForsbergRCDavigonDRSmithDG. A prospective study of risk factors for diabetic foot ulcer: the Seattle Diabetic Foot Study. Diabetes Care. 1999;22:1036-1047.
4.
PatoutCABirkeJAHorsewellRWilliamsDCeriseFP. Effectiveness of compressive diabetes lower extremity amputation prevention program in a predominately low income African-American population. Diabetes Care. 2000;23:1339-1342.
5.
MayfieldJAReiberGEMaynardCCzernieckiJMCapsMTSangeorzanBJ. Survival following lower limb amputation in a veteran population. J Rehabil Res Dev. 2001;28:341-345.
6.
PetersEJChildsMWunderlichRPHarklessLB. Functional status of persons with diabetes-related lower extremity amputation. Diabetes Care. 2001;24:1799-1804.
7.
PoundNChipchaseKTreeceKGameFJeffcoateW. Ulcer-free survival following management of foot ulcers in diabetes. Diabet Med. 2005;22:1306-1309.
8.
IcksAScheerM. Time-dependent impact of diabetes on mortality in patients after major lower extremity amputation: survival in a population-based 5-year cohort in Germany. Diabetes Care. 2011;34:1350-1354.
9.
BoultonAJMvan HoutumWH. The diabetic foot: proceedings of the 5th International Symposium on the Diabetic Foot, 9-12 May 2007, Noordwijkerhout, the Netherlands. Diabet Metab Res Rev. 2008;24(suppl):S1-S193.
10.
HoschJQuirogaCBosmaJPetersEJGArmstrongDGLaveryLA. Outcomes of transmetatarsal amputations in patients with diabetes mellitus. J Foot Ankle Surg. 1997;36:430-434.
11.
PinzurMSGoldJSchwartzDGrossN. Energy demands for walking in dysvascular amputees as related to the level of amputation. Orthopaedics. 1993;15:1033-1073.
12.
WagnerFWJr.Amputation of the foot and ankle: current status. Clin Orthop. 1977;122:62-69.
13.
WagnerFWJr.The dysvascular foot: a system for diagnosis and treatment. Foot Ankle. 1981;2:64-122.
14.
PinzurMSStuckRMSageRHuntNRabinovichZ. Syme ankle disarticulation in patients with diabetes. J Bone Joint Surg Am. 2003;85:1667-1671.
15.
YoungerASEAwwadMAKallaTPde VriesG. Risk Factors for failure of transmetatarsal amputation in diabetic patients: a cohort study. Foot Ankle Int. 2009;30:1177-1182.
16.
LarssonJAgardhCDApelqvistJStenstromA. Clinical characteristics in relation to final amputation level in diabetic patients with foot ulcers: a prospective study of healing below or above the ankle in 187 patients. Foot Ankle Int. 1995;16:69-74.
17.
DickhautSCDeLeeJCPageCP. Nutritional status: importance in predicting wound-healing after amputation. J Bone Joint Surg Am. 1984;66:71-75.
18.
JonesRNMarsallWP. Does the proximity of an amputation, length of time between foot ulcer development and amputation, or glycemic control at the time of amputation affect the mortality rate of people with diabetes who undergo an amputation?Adv Skin Wound Care. 2008;21:118-123.
19.
KaySPMorelandJRSchmitterE. Nutritional status and wound healing in lower extremity amputations. Clin Orthop Relat Res. 1985;(217):253-256.
20.
SpanheimerRGPeterkofskyB. A specific decrease in collagen synthesis in acutely fasted, vitamin C-supplemented, guinea pigs. J Biol Chem. 1985;260:3955-3962.
21.
IrvinTT. Effects of malnutrition and hyperalimentation on wound healing. Surg Gynecol Obstet. 1978;146:33-37.
22.
AkinciBYenerSYesilSYaparNKucukyanvasYBayraktarF. Acute phase reactant predict the risk of amputation in diabetic foot infection. J Am Podiatr Med Assoc. 2011;101:1-6.
CapesSEHuntDMalmbergKPathakPGersteinHC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke. 2001;32:2426-2432.
25.
CapesSEHuntDMalmbergKPathakPGersteinHC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355:773-783.
26.
CaoJJHudsonMJankowskiMWhitehouseFWeaverWD. Relation of chronic and acute glycemic control on mortality in acute myocardial infarction with diabetes mellitus. Am J Cardiol. 2005;96:183-186.
27.
McAlisterFAMajumdarSRBlitzSRoweBHRomneyJMarrieTJ. The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia. Diabetes Care. 2005;28:810-815.
28.
McAlisterFAManJBistritzLAmadHTandonP. Diabetes and coronary artery bypass surgery: an examination of perioperative glycemic control and outcomes. Diabetes Care. 2003;26:1518-1524.
29.
YendamuriSFuldaGJTinkoffGH. Admission hyperglycemia as a prognostic indicator in trauma. J Trauma. 2003;55:33-38.
30.
LjungqvistOSoopMHedströmM. Why metabolism matters in elective orthopedic surgery: a review. Acta Orthop. 2007;78:610-615.
31.
LjungqvistONygrenJThorellA. Insulin resistance and elective surgery. Surgery. 2000;128:757-760.
32.
MarchantMHViensNACookCVailTPBolognesiMP. The impact of glycemic control and diabetes mellitus on perioperative outcomes after total joint arthroplasty. J Bone Joint Surg Am. 2009;91:1621-1629.
33.
RichardsJEKauffmannRMZuckermanSLObremskeyWTMayAK. Relationship of hyperglycemia and surgical-site infection in orthopedic surgery. J Bone Joint Surg Am. 2012;94:1181-1186.
